Profile | GDS5420 / 216019_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 35.18 | 26 |
GSM1296119 | B_lesional_pre-dose | 42.36 | 26 |
GSM1296076 | C_lesional_pre-dose | 23.34 | 18 |
GSM1296092 | D_lesional_pre-dose | 8.08 | 9 |
GSM1296103 | E_lesional_pre-dose | 42.22 | 29 |
GSM1296078 | F_lesional_pre-dose | 7.23 | 7 |
GSM1296107 | G_lesional_pre-dose | 43.21 | 26 |
GSM1296109 | H_lesional_pre-dose | 77.7 | 36 |
GSM1296080 | I_lesional_pre-dose | 57.11 | 34 |
GSM1296090 | J_lesional_pre-dose | 23.73 | 21 |
GSM1296074 | K_lesional_pre-dose | 12.51 | 13 |
GSM1296111 | L_lesional_pre-dose | 62.34 | 31 |
GSM1296099 | M_lesional_pre-dose | 33.97 | 25 |
GSM1296086 | O_lesional_pre-dose | 38.98 | 28 |
GSM1296117 | P_lesional_pre-dose | 55.11 | 29 |
GSM1296113 | Q_lesional_pre-dose | 55.36 | 28 |
GSM1296096 | R_lesional_pre-dose | 38.13 | 28 |
GSM1296105 | S_lesional_pre-dose | 143.51 | 46 |
GSM1296098 | T_lesional_pre-dose | 69.14 | 34 |
GSM1296101 | U_lesional_pre-dose | 106.93 | 42 |
GSM1296121 | V_lesional_pre-dose | 13.4 | 12 |
GSM1296088 | W_lesional_pre-dose | 50.29 | 32 |
GSM1296082 | X_lesional_pre-dose | 13.25 | 14 |
GSM1296115 | Y_lesional_pre-dose | 43.65 | 27 |
GSM1296084 | Z_lesional_pre-dose | 44.87 | 29 |
GSM1296072 | B_lesional_day8 | 90.77 | 38 |
GSM1296069 | L_lesional_day8 | 106.29 | 39 |
GSM1296071 | P_lesional_day8 | 84.5 | 35 |
GSM1296070 | Y_lesional_day8 | 67.3 | 32 |
GSM1296073 | V_lesional_day8 | 25.81 | 20 |
GSM1296034 | A_lesional_day15 | 113.12 | 42 |
GSM1296041 | G_lesional_day15 | 36.6 | 24 |
GSM1296035 | R_lesional_day15 | 38.92 | 29 |
GSM1296038 | U_lesional_day15 | 87.33 | 39 |
GSM1296047 | B_lesional_day15 | 48.11 | 27 |
GSM1296039 | E_lesional_day15 | 55.29 | 32 |
GSM1296042 | H_lesional_day15 | 69.05 | 33 |
GSM1296043 | L_lesional_day15 | 88.79 | 36 |
GSM1296037 | M_lesional_day15 | 151.81 | 47 |
GSM1296046 | P_lesional_day15 | 80.55 | 35 |
GSM1296044 | Q_lesional_day15 | 76.38 | 34 |
GSM1296045 | Y_lesional_day15 | 66.5 | 31 |
GSM1296025 | C_lesional_day15 | 42.83 | 29 |
GSM1296033 | D_lesional_day15 | 75.52 | 38 |
GSM1296027 | I_lesional_day15 | 39.39 | 30 |
GSM1296032 | J_lesional_day15 | 50.64 | 31 |
GSM1296024 | K_lesional_day15 | 85.11 | 40 |
GSM1296031 | W_lesional_day15 | 108.22 | 42 |
GSM1296028 | X_lesional_day15 | 39.6 | 28 |
GSM1296029 | Z_lesional_day15 | 104.6 | 42 |
GSM1296026 | F_lesional_day15 | 102.89 | 42 |
GSM1296030 | O_lesional_day15 | 39.11 | 30 |
GSM1296040 | S_lesional_day15 | 92.44 | 40 |
GSM1296036 | T_lesional_day15 | 181.98 | 50 |
GSM1296048 | V_lesional_day15 | 69.24 | 34 |
GSM1296059 | A_lesional_day43 | 39.19 | 28 |
GSM1296066 | G_lesional_day43 | 34.36 | 22 |
GSM1296060 | R_lesional_day43 | 8.54 | 9 |
GSM1296063 | U_lesional_day43 | 122.87 | 44 |
GSM1296064 | E_lesional_day43 | 105.01 | 43 |
GSM1296067 | H_lesional_day43 | 121.82 | 42 |
GSM1296062 | M_lesional_day43 | 63.96 | 35 |
GSM1296068 | Q_lesional_day43 | 86.62 | 35 |
GSM1296050 | C_lesional_day43 | 50.96 | 30 |
GSM1296057 | D_lesional_day43 | 52.55 | 32 |
GSM1296052 | I_lesional_day43 | 105.78 | 44 |
GSM1296054 | J_lesional_day43 | 130.58 | 45 |
GSM1296049 | K_lesional_day43 | 37.79 | 27 |
GSM1296055 | W_lesional_day43 | 91.81 | 39 |
GSM1296053 | X_lesional_day43 | 55.58 | 33 |
GSM1296058 | Z_lesional_day43 | 94.36 | 41 |
GSM1296051 | F_lesional_day43 | 35.3 | 26 |
GSM1296056 | O_lesional_day43 | 23.92 | 22 |
GSM1296065 | S_lesional_day43 | 102.46 | 41 |
GSM1296061 | T_lesional_day43 | 93.21 | 40 |
GSM1296095 | A_non-lesional_pre-dose | 22.12 | 20 |
GSM1296120 | B_non-lesional_pre-dose | 111.18 | 41 |
GSM1296077 | C_non-lesional_pre-dose | 26.23 | 22 |
GSM1296093 | D_non-lesional_pre-dose | 70.1 | 35 |
GSM1296104 | E_non-lesional_pre-dose | 49.61 | 31 |
GSM1296079 | F_non-lesional_pre-dose | 48.68 | 31 |
GSM1296108 | G_non-lesional_pre-dose | 70.28 | 34 |
GSM1296110 | H_non-lesional_pre-dose | 67.02 | 32 |
GSM1296081 | I_non-lesional_pre-dose | 106.79 | 44 |
GSM1296091 | J_non-lesional_pre-dose | ||
GSM1296075 | K_non-lesional_pre-dose | 35.33 | 26 |
GSM1296112 | L_non-lesional_pre-dose | 104.6 | 38 |
GSM1296100 | M_non-lesional_pre-dose | 105.17 | 41 |
GSM1296087 | O_non-lesional_pre-dose | 28.41 | 25 |
GSM1296118 | P_non-lesional_pre-dose | 74.79 | 33 |
GSM1296114 | Q_non-lesional_pre-dose | 57.04 | 29 |
GSM1296097 | R_non-lesional_pre-dose | 120.2 | 44 |
GSM1296106 | S_non-lesional_pre-dose | 77.37 | 36 |
GSM1296102 | U_non-lesional_pre-dose | 112.57 | 42 |
GSM1296122 | V_non-lesional_pre-dose | 146.41 | 46 |
GSM1296089 | W_non-lesional_pre-dose | 125.74 | 44 |
GSM1296083 | X_non-lesional_pre-dose | 172.42 | 50 |
GSM1296116 | Y_non-lesional_pre-dose | 90.08 | 36 |
GSM1296085 | Z_non-lesional_pre-dose | 41.39 | 28 |